                         SEQUENCE LISTING

<110>  THE TEXAS A&M UNIVERSITY SYSTEM
 
<120>  SELECTIVE SMALL MOLECULE AGONISTS AND PARTIAL AGONISTS OF TRK 
       RECEPTORS

<130>  78090-355252

<140>  PCT/US2022/031754
<141>  2022-06-01

<150>  63/195868
<151>  2021-06-02

<160>  42    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Pepetide fragment

<400>  1

Asp Ile Lys Gly 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  2

Ile Asn Asn Ser 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  3

Asp Gly Lys Gln 
1               


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  4

Asp Glu Lys Gln 
1               


<210>  5
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  5

Asp Met Ser Gly 
1               


<210>  6
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  6

Val Ser Lys Gly 
1               


<210>  7
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  7

Asp Ser Lys Lys 
1               


<210>  8
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  8

Asp Ile Arg Gly 
1               


<210>  9
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  9

Thr Gln Asn Ser 
1               


<210>  10
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  10

Thr Gly Asn Ser 
1               


<210>  11
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  11

Glu Asn Asn Lys 
1               


<210>  12
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  12

Asp Ile Lys Gly Lys 
1               5   


<210>  13
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  13

Asn Ile Asn Asn Ser Val Phe 
1               5           


<210>  14
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  14

Asp Gly Lys Gln Ala 
1               5   


<210>  15
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  15

Asp Glu Lys Gln Ala 
1               5   


<210>  16
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  16

Asp Met Ser Gly Gly 
1               5   


<210>  17
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  17

Ser Lys Gly Gln 
1               


<210>  18
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  18

Asp Ser Lys Lys Arg 
1               5   


<210>  19
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  19

Asp Ile Arg Gly His 
1               5   


<210>  20
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  20

Thr Gln Asn Ser Pro 
1               5   


<210>  21
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  21

Lys Thr Gln Asn Ser Pro Val 
1               5           


<210>  22
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  22

Thr Gln Asn Ser Gly 
1               5   


<210>  23
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  23

Thr Gly Asn Ser Pro 
1               5   


<210>  24
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  24

Glu Asn Asn Lys Leu Val 
1               5       


<210>  25
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  25

Cys Asp Glu Lys Gln Cys 
1               5       


<210>  26
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  26

Cys Ile Asn Asn Ser Cys 
1               5       


<210>  27
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  27

Cys Asp Ile Lys Gly Cys 
1               5       


<210>  28
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  28

Cys Asp Gly Lys Gln Cys 
1               5       


<210>  29
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  29

Cys Glu Asn Asn Lys Cys 
1               5       


<210>  30
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  30

Cys Asp Ile Arg Gly Cys 
1               5       


<210>  31
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  31

Cys Thr Gly Asn Ser Cys 
1               5       


<210>  32
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  32

Cys Thr Gln Asn Ser Cys 
1               5       


<210>  33
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  33

Cys Asp Met Ser Gly Cys 
1               5       


<210>  34
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  34

Cys Val Ser Lys Gly Cys 
1               5       


<210>  35
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  35

Cys Asp Ser Lys Lys Cys 
1               5       


<210>  36
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  36

Cys Asp Leu Arg Gly Cys 
1               5       


<210>  37
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  37

Cys Ala Gly Gly Ser Cys 
1               5       


<210>  38
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  38

Cys Asp Ala Gln Gly Cys 
1               5       


<210>  39
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  39

Cys Asp Ile Lys Gly Cys 
1               5       


<210>  40
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  40

Asp Leu Arg Gly 
1               


<210>  41
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  41

Ala Gly Gly Ser 
1               


<210>  42
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide fragment

<400>  42

Asp Ala Gln Gly 
1               


